Azathioprine 50 MG Oral Tablet
INDICATIONS AND USAGE Azathioprine tablets, USP are indicated as an adjunct for the prevention of rejection in renal homotransplantation. It is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. Renal Homotransplantation Azathioprine tablets, USP are indicated as an adjunct for the prevention of rejection in renal homotransplantation. Experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for HLA antigens, anti-donor or anti-B-cell alloantigen antibody, and other variables. The effect of azathioprine tablets on these variables has not been tested in controlled trials. Rheumatoid Arthritis Azathioprine tablets, USP are indicated for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms. Aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with azathioprine tablets. The combined use of azathioprine tablets with disease modifying anti-rheumatic drugs (DMARDs) has not been studied for either added benefit or unexpected adverse effects. The use of azathioprine tablets with these agents cannot be recommended.
Zydus Pharmaceuticals (USA) Inc.
ROUND YELLOW ZC 59
Related Pills
Azathioprine 50 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
AZATHIOPRINE Tablets USP, 25 mg are yellow, round, flat, radial edge tablets with bisect on one side and other side is plain; one side of the bisect is debossed with logo of "ZD" and other side is debossed with "11" and are supplied as follows: NDC 68382-118-01 in bottles of 100 tablets NDC 68382-118-05 in bottles of 500 tablets
AZATHIOPRINE Tablets USP, 50 mg are yellow, round, flat, beveled edge tablets with bisect on one side; one side of the bisect is debossed with logo of "ZC" and other side is debossed with "59" and other side is plain and are supplied as follows: NDC 68382-003-01 in bottles of 100 tablets NDC 68382-003-05 in bottles of 500 tablets
AZATHIOPRINE Tablets USP, 75 mg are yellow, round, flat, radial-edged tablets with bisect on one side and other side of tablet is plain; one side of the bisect is debossed with "ZD" and other side is debossed with "10" and are supplied as follows: NDC 68382-119-01 in bottles of 100 tablets NDC 68382-119-05 in bottles of 500 tablets
AZATHIOPRINE Tablets USP, 100 mg are yellow, round, flat, radial-edged tablets with bisect on one side and other side of tablet is plain; one side of the bisect is debossed with "ZD" and other side is debossed with "09" and are supplied as follows: NDC 68382-120-01 in bottles of 100 tablets NDC 68382-120-05 in bottles of 500 tablets STORAGE Store at 20°C to 25° C (68°F to 77° F) [See USP Controlled Room Temperature] in a dry place and protect from light. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
More pills like ROUND ZC 59